Monica C Serra1, Joe R Nocera2, Jessica L Kelleher2, Odessa Addison3. 1. Atlanta VA and Emory University School of Medicine, 1670 Clairmont Rd. (151R), Decatur, GA, 30307, USA. monica.christine.serra@emory.edu. 2. Atlanta VA and Emory University School of Medicine, 1670 Clairmont Rd. (151R), Decatur, GA, 30307, USA. 3. Baltimore VA and University of Maryland School of Medicine, Baltimore, MD, USA.
Abstract
PURPOSE OF REVIEW: This literature review summarizes the evidence for and against the impact of prebiotics on brain function and behavior in older adults. RECENT FINDINGS: Current evidence generally supports the intake of prebiotics to increase beneficial gut bacteria concentrations. These bacteria appear to impact endocrine, immunologic, and neuronal communication along the gut-brain axis to alter brain function and behavior. Preliminary evidence in human studies consistently support prebiotics doses of ~ 5-10 g/d as safe to improve brain function (i.e., learning and working memory) and behavior (i.e., anxiety and mood). However, these studies are mainly of short duration (4-12 weeks) and limited to healthy, young, and middle-aged adults. More research is needed to identify a safe and effective dose, duration, and delivery method, particularly among diseased, older adults.
PURPOSE OF REVIEW: This literature review summarizes the evidence for and against the impact of prebiotics on brain function and behavior in older adults. RECENT FINDINGS: Current evidence generally supports the intake of prebiotics to increase beneficial gut bacteria concentrations. These bacteria appear to impact endocrine, immunologic, and neuronal communication along the gut-brain axis to alter brain function and behavior. Preliminary evidence in human studies consistently support prebiotics doses of ~ 5-10 g/d as safe to improve brain function (i.e., learning and working memory) and behavior (i.e., anxiety and mood). However, these studies are mainly of short duration (4-12 weeks) and limited to healthy, young, and middle-aged adults. More research is needed to identify a safe and effective dose, duration, and delivery method, particularly among diseased, older adults.
Authors: Emanuel Schwarz; Johanna Maukonen; Tiina Hyytiäinen; Tuula Kieseppä; Matej Orešič; Sarven Sabunciyan; Outi Mantere; Maria Saarela; Robert Yolken; Jaana Suvisaari Journal: Schizophr Res Date: 2017-04-22 Impact factor: 4.939
Authors: Marco A R Vinolo; Hosana G Rodrigues; Elaine Hatanaka; Fábio T Sato; Sandra C Sampaio; Rui Curi Journal: J Nutr Biochem Date: 2010-12-16 Impact factor: 6.048
Authors: Viorica Braniste; Maha Al-Asmakh; Czeslawa Kowal; Farhana Anuar; Afrouz Abbaspour; Miklós Tóth; Agata Korecka; Nadja Bakocevic; Lai Guan Ng; Ng Lai Guan; Parag Kundu; Balázs Gulyás; Christer Halldin; Kjell Hultenby; Harriet Nilsson; Hans Hebert; Bruce T Volpe; Betty Diamond; Sven Pettersson Journal: Sci Transl Med Date: 2014-11-19 Impact factor: 17.956
Authors: Kristin Schmidt; Philip J Cowen; Catherine J Harmer; George Tzortzis; Steven Errington; Philip W J Burnet Journal: Psychopharmacology (Berl) Date: 2014-12-03 Impact factor: 4.530